
|Videos|January 14, 2022
Dupilumab in Atopic Dermatitis and What Pharmacists Should Know
It is important for pharmacists to know the latest updates on the right treatment options for atopic dermatitis.
Advertisement
Pharmacy Times spoke with Dr. Peter Lio, assistant professor of dermatology & pediatrics at Northwestern University Feinberg School of Medicine, about dupilumab associated Ocular Surface Disease in patients with atopic dermatitis.
Dr. Lio discussed what drew him and his team into the topic of dupilumab for studies about atopic dermatitis and any significant findings that pharmacists should know when counseling their patients.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
New CKD Outcome Set Tells Pharmacists What to Measure
3
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
4
Dosing, Monitoring, and Counseling: The Pharmacist's Role in TKI Therapy for Systemic Mastocytosis
5





































































































